Search Results - "CHINNASAMY, Dhanalakshmi"

Refine Results
  1. 1

    Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia by Tran, Eric, Chinnasamy, Dhanalakshmi, Yu, Zhiya, Morgan, Richard A, Lee, Chyi-Chia Richard, Restifo, Nicholas P, Rosenberg, Steven A

    Published in The Journal of experimental medicine (03-06-2013)
    “…Fibroblast activation protein (FAP) is a candidate universal target antigen because it has been reported to be selectively expressed in nearly all solid tumors…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Neurosupportive Role of Vanillin, a Natural Phenolic Compound, on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells by Justin Thenmozhi, Arokiasamy, Nataraj, Jagatheesan, Manivasagam, Thamilarasan, Dhanalakshmi, Chinnasamy, Essa, Musthafa Mohamed

    “…Vanillin, a phenolic compound, has been reported to offer neuroprotection against experimental Huntington’s disease and global ischemia by virtue of its…”
    Get full text
    Journal Article
  5. 5

    Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency by Dhanalakshmi, Chinnasamy, Janakiraman, Udaiyappan, Moutal, Aubin, Fukunaga, Kohji, Khanna, Rajesh, Nelson, Mark A.

    Published in Neurobiology of disease (01-02-2021)
    “…The TATA-box binding protein associated factor 1 (TAF1) is part of the TFIID complex that plays a key role during the initiation of transcription. Variants of…”
    Get full text
    Journal Article
  6. 6

    The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome by Janakiraman, Udaiyappan, Dhanalakshmi, Chinnasamy, Yu, Jie, Moutal, Aubin, Boinon, Lisa, Fukunaga, Kohji, Khanna, Rajesh, Nelson, Mark A.

    Published in Neurobiology of disease (01-09-2020)
    “…T-type calcium channels, in the central nervous system, are involved in the pathogenesis of many neurodegenerative diseases, including TAF1 intellectual…”
    Get full text
    Journal Article
  7. 7

    Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice by Chinnasamy, Dhanalakshmi, Yu, Zhiya, Theoret, Marc R, Zhao, Yangbing, Shrimali, Rajeev K, Morgan, Richard A, Feldman, Steven A, Restifo, Nicholas P, Rosenberg, Steven A

    Published in The Journal of clinical investigation (01-11-2010)
    “…Immunotherapies based on adoptive cell transfer are highly effective in the treatment of metastatic melanoma, but the use of this approach in other cancer…”
    Get full text
    Journal Article
  8. 8

    TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex by Janakiraman, Udaiyappan, Yu, Jie, Moutal, Aubin, Chinnasamy, Dhanalakshmi, Boinon, Lisa, Batchelor, Shelby N., Anandhan, Annaduri, Khanna, Rajesh, Nelson, Mark A.

    Published in Neurobiology of disease (01-12-2019)
    “…TAF1/MRSX33 intellectual disability syndrome is an X-linked disorder caused by loss-of-function mutations in the TAF1 gene. How these mutations cause…”
    Get full text
    Journal Article
  9. 9

    Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson's disease by Janakiraman, Udaiyappan, Manivasagam, Thamilarasan, Thenmozhi, Arokiasamy Justin, Dhanalakshmi, Chinnasamy, Essa, Musthafa Mohamed, Song, Byoung-Joon, Guillemin, Gilles J

    Published in Physiology & behavior (01-05-2017)
    “…Abstract Depression is frequently encountered during Parkinson's disease (PD) as a non-motor feature, which has been reported to cause and exaggerate motor…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI by Chinnasamy, Dhanalakshmi, Milsom, Michael D, Shaffer, James, Neuenfeldt, James, Shaaban, Aimen F, Margison, Geoffrey P, Fairbairn, Leslie J, Chinnasamy, Nachimuthu

    Published in Virology journal (15-03-2006)
    “…A number of gene therapy applications would benefit from vectors capable of expressing multiple genes. In this study we explored the feasibility and efficiency…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer by SHRIMALI, Rajeev K, ZHIYA YU, THEORET, Marc R, CHINNASAMY, Dhanalakshmi, RESTIFO, Nicholas P, ROSENBERG, Steven A

    Published in Cancer research (Chicago, Ill.) (01-08-2010)
    “…Adoptive cell transfer (ACT)-based immunotherapies can mediate objective cancer regression in animal models and in up to 70% of patients with metastatic…”
    Get full text
    Journal Article
  15. 15

    Local Delivery of Interleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice by CHINNASAMY, Dhanalakshmi, ZHIYA YU, KERKAR, Sid P, LING ZHANG, MORGAN, Richard A, RESTIFO, Nicholas P, ROSENBERG, Steven A

    Published in Clinical cancer research (15-03-2012)
    “…We investigated the feasibility of delivering the proinflammatory cytokine interleukin (IL)-12 into tumor using T cells genetically engineered to express a…”
    Get full text
    Journal Article
  16. 16

    Simultaneous Targeting of Tumor Antigens and the Tumor Vasculature Using T Lymphocyte Transfer Synergize to Induce Regression of Established Tumors in Mice by CHINNASAMY, Dhanalakshmi, TRAN, Eric, ZHIYA YU, MORGAN, Richard A, RESTIFO, Nicholas P, ROSENBERG, Steven A

    Published in Cancer research (Chicago, Ill.) (01-06-2013)
    “…Most systemic cancer therapies target tumor cells directly, although there is increasing interest in targeting the tumor stroma that can comprise a substantial…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20